Related Experiment Video
Updated: Jun 21, 2026
07:32
A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System
Published on: August 30, 2019
Humanized mice for modeling human infectious disease: challenges, progress, and outlook
Nicolas Legrand1, Alexander Ploss, Rudi Balling
1Department of Cell Biology and Histology, Academic Medical Center of the University of Amsterdam, Amsterdam 1105 AZ, The Netherlands.
Cell Host & Microbe
|July 21, 2009
Summary
Humanized mouse models show promise for developing new hepatitis, HIV, and malaria treatments. Challenges remain in creating affordable therapies and vaccines to combat these widespread infectious diseases.
Area of Science:
- Infectious Diseases
- Immunology
- Translational Medicine
Background:
- Hepatitis viruses, HIV, and malaria infect over 800 million people globally.
- These infectious diseases cause over 5 million deaths annually.
- Urgent need exists for effective and affordable therapies and vaccines.
Purpose of the Study:
- To discuss the potential of humanized mouse models in combating hepatitis, HIV, and malaria.
- To highlight the challenges associated with developing treatments using these models.
Main Methods:
- Review of current research on humanized mouse models for infectious diseases.
- Analysis of the utility and limitations of these models in preclinical studies.
Main Results:
- Humanized mouse models offer a platform for studying pathogen-host interactions.
- These models can aid in the evaluation of therapeutic candidates and vaccine efficacy.
- Significant challenges include model variability, cost, and translation to human outcomes.
Conclusions:
- Humanized mouse models are valuable tools for infectious disease research.
- Further development is needed to overcome challenges and accelerate the creation of new treatments.
- Optimizing these models is crucial for developing accessible therapies and vaccines against hepatitis, HIV, and malaria.
